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The staphylococcal nuclease, encoded by the nuc1 gene, is an important virulence factor of Staphylococcus aureus. However, 
the physiological role of the nuclease has not been fully characterized. The current study observed that biofilm development 
could be prevented in staphylococcal nuclease-producing strains of S. aureus; however, when the nuc1 gene was knocked out, 
the ability to form a biofilm significantly increased. Scanning electron and confocal scanning laser microscopy were used to 
evaluate the role of the nuc1 gene in biofilm formation. Moreover, the nuc1 gene product, staphylococcal nuclease, and re-
combinant NUC1 protein were found to have a visible effect on other biofilm-forming bacteria, such as Pseudomonas aeru-
ginosa, Actinobacillus pleuropneumoniae, and Haemophilus parasuis. The current study showed a direct relationship between 
staphylococcal nuclease production and the prevention of biofilm development. The findings from this study underscore the 
important role of staphylococcal nuclease activity to prevent biofilm formation in S. aureus. They also provided evidence for 
the biological role of staphylococcal nucleases in other organisms.  
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Bacterial biofilms are structured communities of cells en-
closed in a self-produced hydrated polymeric matrix adher-
ent to an inert or living surface [1]. Formation of these ses-
sile communities and their inherent resistance to antibiotics 
and host immune attack are the basis of many persistent, 
often chronic, bacterial infections [2]. Staphylococcus au-
reus has evolved into highly adaptable human pathogens 
responsible for many infections ranging from folliculitis and 
foodborne intoxications to severe endocarditis, osteomyeli-
tis, or septicemia [3]. Besides the production of exotoxins 
and surface proteins, the formation of highly organized 
multicellular complexes-biofilms is increasingly being  
recognized as an important virulence factor in Staphylo-
coccus spp. [4]. Most Staphylococcus spp. have the ability 
to adhere and form biofilms, which exhibit a distinct phe-
notype and present a serious clinical problem [5]. Coloniza-
tion alone by this bacterium does not usually lead to adverse 
events; however, once the epithelial and mucosal surfaces 
have been breached, serious disease can result [6]. Further-
more, inside the biofilm, S. aureus becomes more resistant 
to antibiotic treatments and the actions of the immune sys-
tem [7]. Consequently, staphylococcal-biofilm-associated 
infections of this type are difficult to eradicate, and most 
can be eliminated only by the removal and substitution of 
the contaminated implant [3]. 
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Many studies have dedicated great effort to identifying 
factors involved in S. aureus biofilm development [8,9]. 
These studies have shown that staphylococcal biofilms are 
multifactorial and influenced profoundly by the infection 
milieu [6]. Until now, many S. aureus genes that contribute 
to its biofilm-forming ability have been reported, including 
agr, sarA, sigB, ica, rbf, tcaR, arlRS, alsSD, and surface 
adhesions genes such as bap, spa, fnbPA, fnbPB, and sasG 
[8,10–12]. Although the expression of the ica operon is of 
central importance in generating biofilm, the roles of other 
factors and co-factors have yet to be determined [13]. Of 
particular importance is the observation that most S. aureus 
clinical isolates possess and express the ica operon under 
various growth conditions, but many are incapable of bio-
film development under the same conditions [6,13]. These 
findings indicate that our understanding of the molecular 
mechanisms contributing to biofilm formation is incomplete, 
and underscores the existence of other factors.  
Recent developments have revealed that the biofilm ma-
trix is a complex mixture of macromolecules, including 
poly-N-acetylglucosamine (PNAG), proteins, and DNA 
[14,15]. Cynthia et al. [2] found that extracellular DNA was 
required for the initial establishment of P. aeruginosa bio-
films. It was also shown that bacterial extracellular genomic 
DNA was an important structural component of the S. au-
reus biofilm matrix [11,15]. Given this information, com-
pounds capable of dissolving matrix components (proteases, 
DNases, or glycoside hydrolases) can prevent the formation 
of biofilms or disrupt established biofilms.  
S. aureus has the ability to produce a wide variety of ex-
oenzymes, including nucleases, proteases, lipases, hyalu-
ronidase, and collagenase [16], and staphylococcal nuclease 
is known to be an important marker unique to S. aureus and 
used as an indicator of S. aureus contamination [17]. This 
nuclease has the ability to degrade nucleic acids by hydro-
lyzing the phosphodiester bonds found in DNA and RNA 
yielding 3′-mononucleotides [18]. Our previous work has 
shown that two thermostable nucleases are present in S. 
aureus: The nuc1 gene was shown to encode the staphylo-
coccal nuclease, and the nuc2 gene encoded the thermonu-
clease. The activity of the staphylococcal nuclease was 
found to be much higher than that of the thermonuclease in 
S. aureus [16]. Therefore, we postulated that the staphylo-
coccal nuclease could play an important role in the preven-
tion of biofilm development and formation in nucle-
ase-producing S. aureus. The current study investigated the 
potential role of staphylococcal nucleases in biofilm for-
mation in S. aureus and other biofilm-forming bacteria.  
1  Materials and methods  
1.1  Bacterial strains, media, and culture conditions 
S. aureus strain RN4220 was kindly donated by Dr. Karen 
Battista (International Association for Food Protection, 
Kraft Foods North America). S. aureus RNnuc1 and 
RNnuc1-complement were constructed previously [16]. 
The strains and sources of biofilm formation bacteria are as 
follows: Pseudomonas aeruginosa CCTTCC AB93066 ob-
tained from the China Center for Type Culture Collection, 
Wuhan University; Actinobacillus pleuropneumoniae (APP) 
Hubei 0504 and Haemophilus parasuis (HPS) 0322 pro-
vided by Huazhong Agricultural University. All bacteria 
were initiated using fresh overnight cultures grown at 37°C 
on tryptic soy agar (TSA) or in tryptic soy broth (TSB) 
(Difco Laboratories, Detroit, MI, USA).  
1.2  Expression of recombinant NUC1 and preparation 
of culture supernatant 
Recombinant plasmid, pET-17nuc1, constructed previously 
[16], was used to transform Escherichia coli BL21(DE3). 
The expression of the target protein was induced by addi-
tion of isopropyl--D-thiogalactopyranoside (IPTG). The 
supernatants from S. aureus strain RN4220 cultures were 
harvested by centrifugation. The enzymatic activities of the 
recombinant protein NUC1 and the culture supernatant of S. 
aureus, including staphylococcal nuclease, were tested on 
toluidine blue-DNA plates.  
1.3  Glass tube biofilm assay 
The ability to form biofilms was tested using a method pre-
viously described by Jin et al. [19]. Briefly, borosilicate 
glass tubes (13 mm×100 mm) filled with 1 mL of TSB were 
inoculated with 20 L of inocula. After 18 h incubation at 
37°C with circular agitation (150 r min1), the contents of 
each tube were removed using an injector. The tubes were 
stained with 1.5 mL of 1% Hucker crystal violet solution at 
room temperature for 5 min. The dye solution was then re-
moved from the tubes, the tubes were rinsed under tap water 
for 3–5 min until no color was observed in the rinse water 
and excess water was then removed from the tubes. 
1.4  Microtiter plate assay for biofilm formation 
Quantification of biofilm formation on abiotic surfaces was 
assessed as previously described [20,21]. The wells of ste-      
rile 96-well flat-bottomed polystyrene microplates were 
filled with 100 L TSB and 10 L of overnight inocula was 
added to each well before the plates were covered and in-
cubated aerobically at 37°C for 36 h. Each bacterium was 
tested in triplicate. To visualize biofilms, the contents of the 
wells were aspirated and the wells washed three times with 
200 L sterile phosphate-buffered saline (PBS) to remove 
loosely adherent cells. The remaining attached bacteria were 
fixed with 100 L methanol for 15 min. After drying in air, 
the wells were stained with 100 L 1% crystal violet solu-
tion for 5 min at room temperature. Excess stain was rinsed 
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off by placing the plate under running tap water. Thereafter, 
the plates were dried in a 37°C incubator for approximately 
30 min to ensure they were completely dry. After the ad-
herent cells were resolubilized with 100 L 33% (v/v) gla-
cial acetic acid, the optical density (A) of each well was 
obtained at 630 nm using a Sunrise absorbance reader 
(Tecan, Maennedorf, Switzerland). All tests were performed 
three times and the values averaged. A values from the wells 
that had not been inoculated with bacteria were used as 
negative controls. The cut-off value (Ac) for determining a 
biofilm producer was defined as twice the negative control 
value. Based on A values, strains were classified as 
non-biofilm producers (AAc), weak biofilm producers 
(AcA2×Ac) or strong biofilm producers (2×AcA). For P. 
aeruginosa CCTTCC AB93066, A. pleuropneumoniae 
(APP) HuBei 0504, and H. parasuis (HPS) 0322, each bac-
terium was added to the supernatants of S. aureus including 
staphylococcal nuclease (20 L), recombinant protein 
NUC1 (20 L), and 10 U of DNase I per well into the cul-
ture for 12 h, and assayed after 36 h of growth. Mean values 
of three independent experiments were calculated and each 
bacterium was performed in triplicate.  
1.5  Scanning electron microscopy (SEM) 
Biofilms of the S. aureus strains were formed on 22 mm×22 
mm glass coverslips (SAIL BRAND, China) and were 
placed at a 55° angle in a six-well polystyrene cell culture 
plate (FALCON, Becton Dickinson and Company, Franklin 
Lakes, USA) that had been filled with 4 mL of TSB with a 
1:100 dilution of an overnight bacterial culture for 24, 36, or 
72 h. SEM was performed as previously described [22]. 
Images were viewed using a JSM-6390/LV scanning elec-
tron microscope. 
1.6  Confocal scanning laser microscopy 
For observation of bacterial biofilm by confocal scanning 
laser microscopy (CSLM), the method described by Rice et 
al. [11] was used with slight modification. Briefly, biofilm 
formation of S. aureus and other bacteria were grown on 22 
mm×22 mm glass coverslips (SAIL BRAND, China) and 
placed in six-well polystyrene microtiter plates (FALCON, 
Becton Dickinson and Company, Franklin Lakes USA) that 
had been filled with 4 mL of TSB with a 1:100 dilution of 
an overnight bacterial culture. For incubations of 72 h, the 
coverslips were rinsed with distilled water to remove 
non-adherent bacteria and stained with LIVE/DEAD Bac-
LightTm Bacterial Viability Kit solution. Samples were 
stored in physiological saline for a maximum of 15 min 
before being covered with distilled water and gently washed 
twice. Biofilm images were collected by CLSM using a 
LSM 510 META confocal scanning system (Zeiss, Germa-
ny). Fluorescence was detected by excitation at 488 nm and 
emission was collected with a 500–530 nm and >615 nm 
bandpass filter. All Z-sections were collected at 1-m in-
tervals by using a Zeiss Immersol 518F objective lens. Im-
age acquisition and processing was performed by using a 
LSM Image Browser (Zeiss, Germany). Each strain was 
examined on at least three separate occasions and the aver-
age depth of the biofilm was determined for each strain us-
ing five independent Z-section measurements. 
1.7  Statistical analysis 
A values were collected from three independent experiments. 
Absorbance values from crystal violet staining assays were 
evaluated for statistically significant differences using Stu-
dent’s unpaired two-sided t-test. Bars in the figures indicate 
standard error from the mean.  
2  Results 
2.1  Staphylococcal nuclease affects S. aureus biofilm 
formation 
Staphylococcal nuclease activity was determined for paren-
tal, mutant (Δnuc1), and complement strains in our previ-
ous work [16]. Both the parent strain and complement strain 
exhibited strong nuclease activity, whereas the pink zone 
size of the mutant strain was significantly smaller than the 
parent and complement strains, showing that culture super-
natants of the mutant strain (RNnuc1) displayed the high-
est decrease in nuclease activity [16].  
The present study showed that there was a close correla-
tion between staphylococcal nuclease activity and biofilm 
formation and stability, where staphylococcal nuclease 
could disrupt or prevent the formation of S. aureus biofilms 
(Figures 1 and 2). The biofilms were washed, stained with 
crystal violet, and retained biomass was quantified by 
measuring the absorbance of each well at an absorbance of 
630 nm. By measuring A values at the levels of biofilm 
formation, the nuc1 knock-out strain, RNnuc1, was 
demonstrated to be a robust biofilm former. The P-value 
was 0.002351<0.0025 which represented the significant 
diversity of biofilm formation among S. aureus RNnuc1, 
parental strain and its complemented strain (Figure 1A). 
The strain RNnuc1 had an increased biofilm adherence. 
Accordingly, the formation ability of biofilm also varied 
considerably in the glass tube assay. The parental strain and 
its complemented strain showed weak biofilm-forming abil-
ities (AcA2×Ac); however, the nuc1 mutant strain was 
significantly different with a strong biofilm-forming ability 
(A2×Ac) (Figure 1B). SEM was used to observe differ-
ences in the three-dimensional (3D) structures of biofilms 
formed by the three strains (Figure 2A). The RN4220 and 
RNnuc1- complement strains were observed to have only 
several planktonic cells on the surface of coverslips, while 
the nuc1 knocked-out strain, RNnuc1, was able to form  
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Figure 1  Quantitative analysis of biofilm formation. A, Microtiter plate 
assay for biofilm formation among S. aureus nuc1 mutant strain (RNnuc1), 
parental strain (RN4220), and its complement strain (RNnuc1-comple-    
ment). Mean values from three independent experiments, each performed 
in triplicate, are shown. Bars indicate the standard error from the mean. B, 
Biofilm adherence assay among S. aureus RNnuc1, RN4220, and  
RNnuc1-complement after 18 h. 
3D biofilm structures. Figure 2B shows the dynamic biofilm 
development and formation procedure of strain RNnuc1 at 
24, 36, and 72 h. The loss of staphylococcal nuclease activ-
ity as a result of the nuc1 knock-out significantly increased 
biofilm development (Figures 1 and 2). The presence of 
staphylococcal nuclease was shown to prevent biofilm de-
velopment in the parental and RNnuc1-complement strains. 
Furthermore, biofilm formation by the RN4220 nuc1 mutant 
and its complement strain were also assessed by CLSM. As 
shown in Figure 3, notable differences were observed 
among the nuc1 mutant, wild-type and complemented 
strains after staining with a viability stain for bacteria. Only 
the nuc1 mutant strain showed a high level of fluorescence 
indicating living cells on the surface of the coverslip with an 
average depth of (16±0.7) m. Other strains showed red 
fluorescence indicating dead cells with an average depth of 
(2±0.4) m. Interestingly, the nuc1 mutant strain with 
DNase I treatment produced similar results as the staphylo-
coccal nuclease-producing strains with red fluorescence. 
2.2  Staphylococcal nuclease affects biofilm formation 
by other bacteria 
To further evaluate the influence of staphylococcal nuclease 
on biofilm formation by other bacteria, three biofilm-form-      
ing bacteria (P. aeruginosa, APP, and HPS) were assayed in 
this study. As shown in Figure 4, the culture supernatant 
containing staphylococcal nuclease and the recombinant 
NUC1 protein had different effects on the biofilm formation 
of the three different bacteria. There was a 2.5-fold decrease 
(P<0.001) in biofilm formation for the P. aeruginosa strain, 
while HPS (P<0.05) and APP (P<0.05) only had slightly 
decreased biofilm formation (Figure 4). Obvious differences 
in the dimensional biofilm structures were detected by 
CLSM (Figure 5). The staphylococcal nuclease and recom-
binant NUC1 protein were both shown to inhibit and de-
crease the development of biofilm formation for the three 
different bacteria, suggesting that S. aureus nucleases could 
possibly have profound effects on biofilm formation for 
other bacteria. 
3  Discussion 
The opportunistic pathogen, S. aureus, and other Staphylo- 
coccus spp. are able to form biofilms on host tissues and 
implanted medical devices often causing chronic infections 
[12]. While some genes associated with biofilm develop-
ment have been identified, the focus of the current study  
 
 
Figure 2  SEM analysis of biofilm formation. SEM of biofilms for S. aureus nuc1 mutant strain (RNnuc1), parental strain (RN4220), and its complement 
strain (RNnuc1-complement) at 72 h. 10000× magnification. B, SEM analysis for biofilm development of nuc1 mutant strain RNnuc1 at different culture  
times (24, 36, and 72 h). 
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Figure 3  CLSM analysis of biofilms. Formation biofilms by nuc1 mutant strain RNnuc1, parental strain RN4220, its complement strain 
RNnuc1-complement and RNnuc1 with DNase I treatment. All strains were grown for 72 h and stained with a viability stain. Representative orthogonal 
views are shown at 630× magnification with three independent experiments. Arrow indicates the top of the biofilms. Top panels show single sections  
through the X-Y plane, and the bottom panels are single sections through the X-Z plane. 
 
Figure 4  Microtiter plate assay for biofilms formation among Pseudomonas aeruginosa (A), Actinobacillus pleuropneumoniae (APP) (B) and Haemophi-
lus parasuis (HPS) (C) with different treatments. All bacteria were respectively added to supernatants of S. aureus that contained staphylococcal nuclease (1), 
recombinant NUC1 protein (2), and DNase I (3) into the 12 h culture and assayed after 36 h of growth. Mean values of three independent experiments, each  
performed in triplicate, are shown. Bars represent the standard error from the mean. 
 
 
Figure 5  CLSM analysis of biofilms formation by Pseudomonas aeru-
ginosa, Actinobacillus pleuropneumoniae (APP) and Haemophilus parasu-
is (HPS) after 72 h growth. Biofilms were stained with viability. Left pan-
els show a control culture without any treatment and right panels  
show 12 h cultures treated with recombinant NUC1 protein. 
was on the role of the staphylococcal nuclease in biofilm 
formation. The results of this study showed a new way to 
control biofilm formation. We examined and demonstrated 
the role of the nuc1 gene in S. aureus biofilm development 
and formation. Furthermore, we also provided evidence for 
the biological role of the staphylococcal nuclease in inhib-
iting biofilm formation of other bacteria.  
In the present study, the analysis of the S. aureus 
RN4220 strain and its isogenic nuc1 mutant (RNnuc1) in 
the context of biofilm formation led to the discovery that 
staphylococcal nuclease contributes to the prevention of 
biofilm formation. Mutation of the nuc1 gene resulted in 
significantly increased biofilm formations suggesting that 
biofilm formation could be prevented in staphylococcal 
nucleases-producing strains under normal conditions. These 
results emphasize the role of the staphylococcal nuclease in 
biofilm formation.  
Our previous work has revealed that most of the S. aure-
us strains possess nuc1 and nuc2 genes that encode staphy-
lococcal nuclease and thermonuclease, respectively. The 
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activity of staphylococcal nuclease is evidently higher than 
that of thermonuclease [16]. In the current study, nuc1 gene 
knock-out resulted in a notable increase in biofilm for-
mation. CLSM and SEM were used to observe the diversity 
of different bacteria in the formation of biofilms. As ex-
pected, high levels of biofilm formation ability were ob-
served in the mutant strain RNnuc1, whereas biofilm for-
mation was barely detectable for the parental strain, com-
plemented strain, and the mutant strain with DNase I treat-
ment. It is likely that extracellular genomic DNA, an im-
portant structural component of the S. aureus biofilm matrix 
[15,23,24], is broken down by the staphylococcal nuclease 
in staphylococcal nuclease-producing strains, preventing the 
adherence of cells for the formation of biofilm. Furthermore, 
staphylococcal nuclease likely prevents biofilm formation 
and promotes programmed cell death, resulting in the ob-
servation of many dead cells in biofilms. By contrast, living 
cells were present in biofilms produced by the nuc1 gene 
knock-out strain as a result of the loss of staphylococcal 
nuclease activities. In agreement with an earlier study [15], 
the staphylococcal thermonuclease may degrade extracellu-
lar genomic DNA (eDNA) as a means to promote biofilm 
dispersal.  
In S. aureus, biofilm formation has been shown to in-
volve both ica-mediated biofilm and ica-independent bio-
film development mechanisms [13]. Bacterial surface pro-
teins, such as Aap and Bap, could mediate polysaccharide 
intercellular adhesin/PNAG-independent intercellular ac-
cumulation during biofilm development [13]. However, our 
study highlighted a novel role of staphylococcal nucleases 
in ica-independent biofilm mechanisms. Our research may 
also explain why the ica locus is maintained, expressed, and 
regulated in many staphylococcus clinical isolates incapable 
of biofilm formation. Staphylococcal nucleases should have 
a great potential for use in the removal of biofilms from 
device-related infections. Several studies have suggested 
that DNase I treatment disrupts P. aeruginosa biofilm 
grown in vitro; which has been used in combination with 
antibiotics to treat P. aeruginosa infections in cystic fibrosis 
patients [25,26]. Similarly, treatments of streptococcal bio-
film with DNase I have a negative effect on biofilm adher-
ence [11,27,28]. To further evaluate the relative efficacy of 
staphylococcal nuclease, we carried out additional analyses. 
The current study showed that staphylococcal nuclease and 
recombinant NUC1 protein were able to prevent biofilm 
formation by P. aeruginosa, APP, and HPS. Staphylococcal 
nuclease-producing S. aureus strains were also shown to 
have a greater ability to interfere with biofilm adherence of 
S. aureus or other biofilm-formation bacteria.  
To date, the production of exotoxins and surface proteins, 
including staphylococcal nucleases, has been recognized as 
important virulence factors in S. aureus [29]. In this context, 
staphylococcal nuclease was seen to have a novel role pre-
venting the generation of biofilms and, therefore, virulence. 
This could explain how biofilm formation is believed to 
have an important role in the pathogenesis of S. epidermidis 
infections, and might be related to the emergence of S. epi-
dermidis as a new pathogen [4,30,31]. Before the advent of 
modern medicine, S. epidermidis was rarely pathogenic [29]. 
S. epidermidis infections were predominantly associated 
with medical devices, such as intravascular devices or im-
planted prosthetic devices. S. epidermidis and some S. au-
reus strains do not possess the nuc1 gene, which means that 
these bacteria do not have the ability to produce staphylo-
coccal nucleases. Therefore, our results could explain why S. 
epidermidis and some S. aureus strains have the ability to 
form biofilms leading to device-related infections. Since the 
capacity of S. epidermidis and S. aureus to form biofilms is 
an important virulence factor in the development of de-
vice-related infections [13,31], we presume that the majori-
ty of biofilm-mediated device-related infections are caused 
by S. epidermidis and some of S. aureus that do not possess 
the nuc1 gene. These conclusions are likely to be the focus 
of future studies.  
We have presented evidence for the biological role of 
staphylococcal nuclease in biofilm formation. Our study 
demonstrated the role staphylococcal nuclease has prevent-
ing biofilm development and formation by S. aureus and 
other biofilm-forming bacteria. This suggests that staphy-
lococcal nucleases and DNase I treatment inhibit biofilm 
formation and might be beneficial as an early prophylactic 
measure to prevent the establishment of chronic biofilm-     
related infections. A combination of phenotypic and geno-
typic tests is recommended for future investigations of the 
influence of staphylococcal nucleases on biofilm formation 
in more clinically-related S. aureus strains.  
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